Skip to main content

    Cell & Gene Therapy on the platform

    Computational tools for CAR-T design, construct assembly, NK-CAR design, KIR matching, and related scoring workflows.

    cell-therapy

    Some tools on this page are retired

    This page documents working tools alongside tools that have been retired. The retired ones can no longer be run:

    • cart_manufacturing_score — use cart_construct_build for the construct composition; the manufacturing score was withdrawn 2026-10-04 and nothing replaces it
    • cart_safety_predict — use cart_construct_build / cart_scfv_design for construct composition; the CRS and neurotoxicity predictions were withdrawn 2026-10-04 and nothing replaces them
    • nk_cytotoxicity_predict — use nk_car_design / nk_kir_match; the NK cytotoxicity prediction was withdrawn 2026-10-04 and nothing replaces it

    Everything else on this page still works.

    Design and evaluate CAR-T and NK cell therapies end to end — from antigen binder design through construct assembly, safety and manufacturing assessment, and NK-specific receptor and donor-matching analysis. Reach for these tools when your program is a cell therapy rather than a small molecule, and you need computational feasibility scores before committing to wet-lab work. They sit in the translational, experimental-biology arc of discovery, feeding downstream into safety and clinical-trial matching. See the Cell & Tissue overview for where this fits.

    Cell & Gene Therapy overview

    The Cell & Gene Therapy toolkit provides seven complementary tools spanning the CAR-T and NK cell therapy design pipeline. Tools cover antigen binder design, construct engineering, safety assessment, manufacturing evaluation, and NK cell biology. All tools run on hosted GPU compute and return results in 30-180 seconds.

    Three tools currently always fail

    cart_safety_predict, cart_manufacturing_score, and nk_cytotoxicity_predict return an error on every call. Each previously scored its output from a hand-tuned sequence-descriptor heuristic with no trained model or clinical/manufacturing/cytotoxicity dataset behind it, and the backend now refuses to return that as a real prediction rather than ship a fabricated number. Use them only to see the refusal message; the four other tools (cart_scfv_design, cart_construct_build, nk_car_design, nk_kir_match) run and return real results.

    Architecture

    User Query (target antigen, construct config, HLA types, tumor profile)
      --> Intent Detection
           |- CAR-T design --> ScFv Design or Construct Build
           |- Safety assessment --> Safety Predict or Manufacturing Score
           |- NK cell therapy --> NK-CAR Design, KIR Match, or Cytotoxicity Predict
      --> Hosted GPU Compute (30-180 seconds)
      --> Structured Results with Feasibility Scores

    Tool inventory

    CAR-T design tools

    ToolNameDescriptionKey Output
    CAR-T ScFv Designcart_scfv_designGenerates ScFv candidates with optimized CDR regions for target bindingRanked ScFv sequences, binding affinity predictions, humanization scores
    CAR Construct Buildcart_construct_buildAssembles full CAR constructs from ScFv, hinge, transmembrane, and signaling domainsComplete CAR sequence, domain annotations, codon-optimized DNA

    CAR-T evaluation tools

    ToolNameDescriptionKey Output
    CAR-T Safety Predict ⚠︎ always failscart_safety_predictRefuses to run — no trained model backs a CRS/ICANS predictionError only
    CAR-T Manufacturing Score ⚠︎ always failscart_manufacturing_scoreRefuses to run — no trained model backs a manufacturing-feasibility predictionError only

    NK cell therapy tools

    ToolNameDescriptionKey Output
    NK-CAR Designnk_car_designDesigns NK-optimized CAR receptors with NK-specific signalingNK-CAR sequences, signaling configurations, activation predictions
    NK KIR Matchnk_kir_matchScores one HLA allele set against a curated KIR-HLA reference tablePer-KIR-gene match type and alloreactivity, overall score
    NK Cytotoxicity Predict ⚠︎ always failsnk_cytotoxicity_predictRefuses to run — no trained model or assay backs a lysis/EC50 predictionError only

    Capabilities

    ScFv candidate design

    The ScFv design tool generates single-chain variable fragment candidates for a target antigen (sequence or UniProt ID) using deep learning. Optionally seed it with a starting vh_sequence/vl_sequence to optimize an existing lead instead of designing de novo. Choose the linker with linker_type (G4S, flexible, or rigid) and how many candidates to generate with num_designs (default 10).

    CAR construct assembly

    The construct builder assembles a complete chimeric antigen receptor sequence from an scFv plus modular components: hinge (CD8, IgG4, or CD28), transmembrane domain (CD28 or CD8), a costimulatory domain (41BB, CD28, OX40, or ICOS), and the CD3-zeta signaling domain. generation selects 2, 3, or 4 — there's no first-generation (CD3-zeta-only) option.

    Safety and toxicity prediction — always fails

    cart_safety_predict takes a full CAR construct_sequence and target_antigen, but every call returns an error rather than a CRS/neurotoxicity risk level: the previous scores came from an instability-index/GRAVY heuristic with no clinical dataset behind them, and the backend now refuses to ship that as a prediction.

    Manufacturing feasibility scoring — always fails

    cart_manufacturing_score takes a CAR construct_sequence and a delivery vector_type (lentiviral, retroviral, or transposon; default lentiviral), but every call returns an error rather than a feasibility score: the previous scores came from sequence-length/instability formulas with no manufacturing dataset behind them.

    NK-CAR receptor design

    NK-CAR design creates a CAR receptor for a target_antigen using NK-specific components: an activating_receptor (NKG2D, DNAM1, NKp30, or NKp44; default NKG2D), a transmembrane domain (NKG2D, DAP10, or CD28), and an intracellular signaling_domain (DAP10, DAP12, or CD3z_2B4; default DAP10).

    KIR-HLA scoring

    nk_kir_match scores a single set of HLA alleles (hla_alleles) against a curated KIR-HLA reference table, returning per-KIR-gene match type and predicted alloreactivity plus an overall alloreactivity_score. It does not compare a donor genotype against a recipient genotype — the tool interface also accepts donor_kir_genotype, recipient_hla (as gene/allele flag objects), and analysis_type, but the executing backend reads none of them; only hla_alleles affects the result.

    NK cytotoxicity prediction — always fails

    nk_cytotoxicity_predict takes the target cell's HLA expression (target_cell_hla) and optional stress ligands (target_ligands) and NK receptor profile (nk_receptors), but every call returns an error rather than a lysis prediction: the previous numbers came from a Hill-equation-shaped heuristic with no cytotoxicity assay behind them.

    When to use each tool

    I want to...Use this tool
    Design a new CAR-T targeting a specific antigencart_scfv_design
    Assemble a complete CAR constructcart_construct_build
    Assess CRS and neurotoxicity riskcart_safety_predict — currently always returns an error
    Evaluate if a construct can be manufacturedcart_manufacturing_score — currently always returns an error
    Design a CAR for NK cellsnk_car_design
    Score KIR-HLA alloreactivity for one allele setnk_kir_match
    Predict how well NK cells will kill a tumornk_cytotoxicity_predict — currently always returns an error
    Run the working part of the CAR-T design pipelinecart_scfv_design + cart_construct_build

    When to use other tools instead

    I want to...Use this instead
    Validate target antigen expressionOpenTargets associations or other Genomics lookups
    Predict 3D structure of ScFvESMFold, or AlphaFold DB for a known protein
    Dock ScFv to target antigenDiffDock
    Search for antibody sequencesUniProt or the antibody databases
    Assess small molecule drug safetyADMETlab 3 or a Safety Passport
    Search for cell therapy clinical trialsClinicalTrials.gov
    Analyze protein-protein interactionsA STRING interaction lookup

    CAR architecture reference

    cart_construct_build's generation parameter accepts 2, 3, or 4 (default 2) and pairs with a single costimulatory domain choice (41BB, CD28, OX40, or ICOS) plus the fixed CD3-zeta signaling domain. There's no first-generation (CD3-zeta-only, no costimulatory domain) option in this tool.

    Citations

    June CH, et al. CAR T cell immunotherapy for human cancer. Science. 2018;359(6382):1361-1365. doi: 10.1126/science.aar6711

    Liu E, et al. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. N Engl J Med. 2020;382(6):545-553. doi: 10.1056/NEJMoa1910607

    Ruggeri L, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. doi: 10.1126/science.1068440

    Chat Usage

    Example Prompts

    • "Design ScFv candidates for targeting BCMA on multiple myeloma cells"
    • "Build a generation-2 4-1BB/CD3-zeta CAR construct using this ScFv sequence"
    • "Design an NK-CAR with DAP12 signaling for targeting GPC3"
    • "Find the best NK cell donor match for this patient's HLA type"

    Workflow Chaining

    • Feeds into: Safety Passport (toxicity assessment), Compound Passport (combination therapy), Clinical Trial matching, ESMFold/AlphaFold (ScFv structure prediction)
    • Accepts from: Genomics tools (target gene data), UniProt (protein sequences), OpenTargets (target validation), Literature search (clinical evidence), Antibody database tools (existing binder sequences)

    FAQ

    Was this page helpful?

    Loading...